510(k) K061376
K061376 is an FDA 510(k) premarket notification submitted by Theratest Laboratories, Inc. for the device "EL-ANCA: ANTI-MPO, ANTI-PR3, ANTI-MPO AND ANTI-PR3". The FDA issued a decision of Substantially Equivalent on July 20, 2006. The device falls under product code MOB (Test System, Antineutrophil Cytoplasmic Antibodies (Anca)), a Class II device regulated under 21 CFR 866.5660. Theratest Laboratories, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- July 20, 2006
- Date Received
- May 17, 2006
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Test System, Antineutrophil Cytoplasmic Antibodies (Anca)
- Device Class
- Class II
- Regulation Number
- 866.5660
- Review Panel
- IM
- Submission Type